Financial Personal
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosis Strong first half net sales growth of 7.4%* year on year Boehringer Ingelheim
![First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones](https://img.easybranches.com/uploads/news/2024/07/first-half-of-2024-boehringer-ingelheim-progresses-pipeline-at-pace-and-reaches-major-milestones.jpg)
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, reported on Thursday significant progress in its pipeline across key therapeutic areas as it reached major milestones in the first half of the year. Read More
Related
Share this page
Guest Posts by Easy BranchesGet Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.